Top Stories
The digital symptom monitoring platform supports real-time toxicity reporting to healthcare teams via a red, amber and green triage system.
The tool could help identify which patients are most likely to benefit from immunotherapy and stem cell transplantation.
The Avantect test showed strong sensitivity and specificity in patients with multiple risk factors, including type 2 diabetes.
The company emerged from stealth Thursday with undisclosed pre-seed backing from MAVRK Celestia Fund, Kern Venture Group and Digital Neural Infrastructure Holdings.
The smart ring maker raised a $900-million financing in October.
Conference News
Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignanciesFORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO)...
Abstracts span six cancer types, including new data on single-digit parts-per-million ctDNA detectionFREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f...
Accepted ASCO abstracts highlight Mercy's blood-based lung cancer screening and lung nodule triage programs using specimens from the NLST biorepository, which was established to support validation of ...
>6,100 participants with and without cancer have been enrolled, spanning 20 cancer typesFOSTER CITY, Calif., May 26, 2026 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular resid...
RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercializati...
